Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 6, 2004, Pages 1046-1069

  Bellail, Anita C ^a   Hunter, Stephen B ^b   Brat, Daniel J ^b   Tan, Chalet ^a   Van Meir, Erwin G ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Extracellular matrix; Glioma; Invasion; Proteases

Indexed keywords

CADHERIN; CATHEPSIN B; GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; INTEGRIN; MATRIX METALLOPROTEINASE;

BRAIN FUNCTION; CANCER INVASION; CELL HETEROGENEITY; CELL INTERACTION; EXTRACELLULAR MATRIX; GLIOMA CELL; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW;

BRAIN; BRAIN NEOPLASMS; CELL COMMUNICATION; EXTRACELLULAR MATRIX; GLIOMA; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRIN BETA CHAINS; NEOPLASM INVASIVENESS;

EID: 13444275480     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.01.013     Document Type: Review

References (179)

1. Abe T., Mori T., Kohno K., Seiki M., Hayakawa T., Welgus H.G.et al. Expression of 72. kDa type IV collagenase and invasion activity of human glioma cells Clinical & Experimental Metastasis. 12:1994;296-304.
2. Aberle H., Schwartz H., Kemler R. Cadherin-catenin complex: Protein interactions and their implications for cadherin function. Journal of Cellular Biochemistry. 61:1996;514-523.
3. Aboody K.S., Brown A., Rainov N.G., Bower K.A., Liu S., Yang W.et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proceedings of the National Academy of Sciences of United States of America. 97:2000;12846-12851.
4. Akiyama Y., Jung S., Salhia B., Lee S., Hubbard S., Taylor M.et al. Hyaluronate receptors mediating glioma cell migration and proliferation. Journal of Neurooncology. 53:2001;115-127.
5. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Molecular biology of the cell, garland science (4th ed.). New York.
6. Amagasaki K., Sasaki A., Kato G., Maeda S., Nukui H., Naganuma H. Antisense-mediated reduction in thrombospondin-1 expression reduces cell motility in malignant glioma cells. International Journal of Cancer. 94:2001;508-512.
7. Asano K., Kubo O., Tajika Y., Huang M.C., Takakura K., Ebina K.et al. Expression and role of cadherins in astrocytic tumors. Brain Tumor Pathology. 14:1997;27-33.
8. Asano K., Kubo O., Tajika Y., Takakura K., Suzuki S. Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurgical Review. 23:2000;39-44.
9. Baltuch G.H., de Tribolet N., Van Meir E.G. Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system. Journal of Neurooncology. 26:1995;191-198.
10. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Research and Treatment. 24:1993;175-184.
11. Bello L., Francolini M., Marthyn P., Zhang J., Carroll R.S., Nikas D.C.et al. Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery. 49:2001;380-389. (discussion 390).
12. Benedetti S., Pirola B., Pollo B., Magrassi L., Bruzzone M.G., Rigamonti D.et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nature Medicine. 6:2000;447-450.
13. Ben-Yosef Y., Lahat N., Shapiro S., Bitterman H., Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circulation Research. 90:2002;784-791.
14. Bhattacharya A., Lakka S.S., Mohanam S., Boyd D., Rao J.S. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Clinical Cancer Research. 7:2001;267-276.
15. Bianchi E., Cohen R.L., Thor A.T. III, Mizukami I.F., Lawrence D.A., Ljung B.M.et al. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Research. 54:1994;861-866.
16. Bignami A., Hosley M., Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anatomy and Embryology (Berlin). 188:1993;419-433.
17. Bigner, D. D., Mclendon, R. E., & Brunner, J. M. (1998). Russell and Rubinstein's pathology of tumors of the nervous system (6th ed.). New York: Oxford University Press.
18. Bixby J.L., Zhang R. Purified N-cadherin is a potent substrate for the rapid induction of neurite outgrowth. Journal of Cell Biology. 110:1990;1253-1260.
19. Blasi F., Carmeliet P. uPAR: A versatile signalling orchestrator. Nature Reviews: Molecular Cell Biology. 3:2002;932-943.
20. Blouw B., Song H., Tihan T., Bosze J., Ferrara N., Gerber H.P.et al. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 4:2003;133-146.
21. Brat, D. J., & Van Meir E. S. (2004). Vaso-occlusive and pro-thrombotic mechanisms associated with tumor hypoxia, necrosis and accelerated growth in glioblastoma. Laboratory Investigation (in press).
22. Brat, D. J., Castellano-Sanchez, A., Hunter, S. B., Pecot, M. J., Cohen, C., Hammond, E. H., et al. (2004). Pseudopalisading cells in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating population. Cancer Research, 64(3), 920-927.
23. Brekken R.A., Sage E.H. SPARC: A matricellular protein: At the crossroads of cell-matrix communication. Matrix Biology. 19:2001;816-827.
24. Brooks P.C., Stromblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G.et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 85:1996;683-693.
25. Brooks P.C. Role of integrins in angiogenesis. European Journal of Cancer. 32A:1996;2423-2429.
26. Bruses J.L. Cadherin-mediated adhesion at the interneuronal synapse. Current Opinion in Cell Biology. 12:2000;593-597.
27. Burger, P., & Scheithauer, B. W. (1994). Tumors of the central nervous system. Washington, DC: Armed Forces Institute of Pathology.
28. Chen H., Herndon M.E., Lawler J. The cell biology of thrombospondin-1. Matrix Biology. 19:2000;597-614.
29. Chi-Rosso G., Gotwals P.J., Yang J., Ling L., Jiang K., Chao B.et al. Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins. Journal of Biological Chemistry. 272:1997;31447-31452.
30. Chlenski A., Liu S., Crawford S.E., Volpert O.V., DeVries G.H., Evangelista A.et al. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. Cancer Research. 62:2002;7357-7363.
31. Choe G., Park J.K., Jouben-Steele L., Kremen T.J., Liau L.M., Vinters H.V.et al. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clinical Cancer Research. 8:2002;2894-2901.
32. Culty M., Nguyen H.A., Underhill C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. Journal of Cell Biology. 116:1992;1055-1062.
33. de Fraipont F., Nicholson A.C., Feige J.J., Van Meir E.G. Thrombospondins and tumor angiogenesis. Trends in Molecular Medicine. 7:2001;401-407.
34. de Vries T.J., Quax P.H., Denijn M., Verrijp K.N., Verheijen J.H., Verspaget H.W.et al. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. American Journal of Pathology. 144:1994;70-81.
35. Delpech B., Maingonnat C., Girard N., Chauzy C., Maunoury R., Olivier A.et al. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. European Journal of Cancer. 29A:1993;1012-1017.
36. Deryugina E.I., Bourdon M.A., Luo G.X., Reisfeld R.A., Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. Journal of Cell Science. 110:1997;2473-2482.
37. Doherty P., Walsh F.S. The contrasting roles of N-CAM and N-cadherin as neurite outgrowth-promoting molecules. Journal of Cell Science (Supplement). 15:1991;13-21.
38. Edvardsen K., Pedersen P.H., Bjerkvig R., Hermann G.G., Zeuthen J., Laerum O.D.et al. Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Effect on glioma-cell invasion and growth in vivo. International Journal of Cancer. 58:1994;116-122.
39. Edvardsen K., Brunner N., Spang-Thomsen M., Walsh F.S., Bock E. Migratory. International Journal of Developmental Neuroscience. 11:1993;681-690.
40. Eeckhout Y., Vaes G. Further studies on the activation of procollagenase, plasmin and kallikrein, and spontaneous activation. Biochemistry Journal. 166:1977;21-31.
41. Ehtesham M., Kabos P., Kabosova A., Neuman T., Black K.L., Yu J.S. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Research. 62:2002;5657-5663.
42. Ehtesham M., Kabos P., Gutierrez M.A., Chung N.H., Griffith T.S., Black K.L.et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Research. 62:2002;7170-7174.
43. Ellerbroek S.M., Halbleib J.M., Benavidez M., Warmka J.K., Wattenberg E.V., Stack M.S.et al. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Research. 61:2001;1855-1861.
44. Even-Ram S., Uziely B., Cohen P., Grisaru-Granovsky S., Maoz M., Ginzburg Y.et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nature Medicine. 4:1998;909-914.
45. Flannery T., Gibson D., Mirakhur M., McQuaid S., Greenan C., Trimble A.et al. The clinical significance of cathepsin S expression in human astrocytomas. American Journal of Pathology. 163:2003;175-182.
46. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H.et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. British Journal of Cancer. 79:1999;1828-1835.
47. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery. 39:1996;235-250. (discussion 250-2).
48. Giese A., Loo M.A., Rief M.D., Tran N., Berens M.E. Substrates for astrocytoma invasion. Neurosurgery. 37:1995;294-301. (discussion 301-2).
49. Gingras M.C., Roussel E., Bruner J.M., Branch C.D., Moser R.P. Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. Journal of Neuroimmunology. 57:1995;143-153.
50. Gladson C.L. Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. Journal of Neuropathology and Experimental Neurology. 55:1996;1143-1149.
51. Gladson C.L. The extracellular matrix of gliomas: Modulation of cell function. Journal of Neuropathology and Experimental Neurology. 58:1999;1029-1040.
52. Gladson C.L., Wilcox J.N., Sanders L., Gillespie G.Y., Cheresh D.A. Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. Journal of Cell Science. 108:1995;947-956.
53. Graham C.H., Fitzpatrick T.E., McCrae K.R. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood. 91:1998;3300-3307.
54. Graham C.H., Forsdike J., Fitzgerald C.J., Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. International Journal of Cancer. 80:1999;617-623.
55. Gratsa A., Rooprai H.K., Rogers J.P., Martin K.K., Pilkington G.J. Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia. Anticancer Research. 17:1997;4111-4117.
56. Groves M.D., Puduvalli V.K., Hess K.R., Jaeckle K.A., Peterson P., Yung W.K.et al. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. Journal of Clinical Oncology. 20:2002;1383-1388.
57. Grumet M., Milev P., Sakurai T., Karthikeyan L., Bourdon M., Margolis R.K.et al. Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. Journal of Biological Chemistry. 269:1994;12142-12146.
58. Guan J.L. Role of focal adhesion kinase in integrin signaling. International Journal of Biochemistry and Cell Biology. 29:1997a;1085-1096.
59. Guan J.L. Focal adhesion kinase in integrin signaling. Matrix Biology. 16:1997b;195-200.
60. Gumbiner B.M. Regulation of cadherin adhesive activity. Journal of Cell Biology. 148:2000;399-404.
61. Gunia S., Hussein S., Radu D.L., Putz K.M., Breyer R., Hecker H.et al. CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma. Clinical & Experimental Metastasis. 17:1999;221-230.
62. Hamada, Ji, Sawamura, Y., Van Meir, E.G., (1998). CD44 expression and growth factors. Frontiers in Bioscience, 3, D657-D664.
63. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. American Journal of Pathology. 149:1996;273-282.
64. Higuchi M., Ohnishi T., Arita N., Hiraga S., Hayakawa T. Expression of tenascin in human gliomas: Its relation to histological malignancy. Acta Neuropathology (Berlin). 85:1993;481-487.
65. Hsu S.C., Volpert O.V., Steck P.A., Mikkelsen T., Polverini P.J., Rao S.et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Research. 56:1996;5684-5691.
66. Huang Z.Y., Wu Y., Hedrick N., Gutmann D.H. T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Molecular and Cellular Biology. 23:2003;566-578.
67. Hunter S.B., Brat D.J., Olson J.J., Von Deimling A., Zhou W., Van Meir E.G. Alterations in molecular pathways of diffusely infiltrating glial neoplasms: Application to tumor classification and anti-tumor therapy (review). International Journal of Oncology. 23:2003;857-869.
68. Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R.et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clinical & Experimental Metastasis. 17:1999;177-181.
69. Jaworski D.M., Kelly G.M., Piepmeier J.M., Hockfield S. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines. Cancer Research. 56:1996;2293-2298.
70. Jones L.S. Integrins: Possible functions in the adult CNS. Trends in Neuroscience. 19:1996;68-72.
71. Junge C.E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P.J., Brat D.J.et al. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proceedings of the National Academy of Sciences of United States of America. 100:2003;13019-13024.
72. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H.et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. Journal of Cell Biology. 153:2001;893-904.
73. Kintner C. Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell. 69:1992;225-236.
74. Kleihues, P., & Cavenee, W. (2000). World health organization classification of tumors: Pathology and genetics of tumors of the nervous system. Lyon: International Agency for Research on Cancer, IARC Press.
75. Kobayashi T., Honke K., Gasa S., Fujii T., Maguchi S., Miyazaki T.et al. Proteolytic processing sites producing the mature form of human cathepsin D. International Journal of Biochemistry. 24:1992;1487-1491.
76. Koochekpour S., Pilkington G.J., Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. International Journal of Cancer. 63:1995;450-454.
77. Kragh M., Quistorff B., Tenan M., Van Meir E.G., Kristjansen P.E. Overexpression of thrombospondin-1 reduces growth and vascular index but not perfusion in glioblastoma. Cancer Research. 62:2002;1191-1195.
78. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G.et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Research. 63:2003;1138-1143.
79. Kunkel P., Ulbricht U., Bohlen P., Brockmann M.A., Fillbrandt R., Stavrou D.et al. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Research. 61:2001;6624-6628.
80. Kuppner M.C., Van Meir E., Gauthier T., Hamou M.F., de Tribolet N. Differential expression of the CD44 molecule in human brain tumours. International Journal of Cancer. 50:1992;572-577.
81. Kuppner M.C., Van Meir E., Hamou M.-F., de Tribolet N. Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clinical and Experimental Immunology. 81:1990;142-148.
82. Kupprion C., Motamed K., Sage E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. Journal of Biological Chemistry. 273:1998;29635-29640.
83. Lakka S.S., Rajan M., Gondi C., Yanamandra N., Chandrasekar N., Jasti S.L.et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene. 21:2002;8011-8019.
84. Lakka S.S., Bhattacharya A., Mohanam S., Boyd D., Rao J.S. Regulation of the uPA gene in various grades of human glioma cells. International Journal of Oncology. 18:2001;71-79.
85. Le D.M., Besson A., Fogg D.K., Choi K.S., Waisman D.M., Goodyer C.G.et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: A mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. Journal of Neuroscience. 23:2003;4034-4043.
86. Lee Y.S., Bullard D.E., Zalutsky M.R., Coleman R.E., Wikstrand C.J., Friedman H.S.et al. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model. Cancer Research. 48:1988;559-566.
87. Levicar N., Strojnik T., Kos J., Dewey R.A., Pilkington G.J., Lah T.T. Lysosomal enzymes, cathepsins in brain tumour invasion. Journal of Neurooncology. 58:2002;21-32.
88. Li H., Hamou M.F., de Tribolet N., Jaufeerally R., Hofmann M., Diserens A.C.et al. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Research. 53:1993;5345-5349.
89. Li Q., Ahuja N., Burger P.C., Issa J.P. Methylation and silencing of the thrombospondin-1 promoter in human cancer. Oncogene. 18:1999;3284-3289.
90. Loskutoff D.J., Curriden S.A., Hu G., Deng G. Regulation of cell adhesion by PAI-1. APMIS. 107:1999;54-61.
91. Maenpaa A., Kovanen P.E., Paetau A., Jaaskelainen J., Timonen T. Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: Expression of VCAM-1 in gliomas. Acta Neuropathology (Berlin). 94:1997;216-225.
92. Mahesparan R., Read T.A., Lund-Johansen M., Skaftnesmo K.O., Bjerkvig R., Engebraaten O. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathology (Berlin). 105:2003;49-57.
93. Maidment S.L., Rucklidge G.J., Rooprai H.K., Pilkington G.J. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro. Cancer Letters. 116:1997;71-77.
94. Matsunami H., Takeichi M. Fetal brain subdivisions defined by R- and E-cadherin expressions: Evidence for the role of cadherin activity in region-specific, cell-cell adhesion. Developmental Biology. 172:1995;466-478.
95. McCormick D. Secretion of cathepsin B by human gliomas in vitro. Neuropathology and Applied Neurobiology. 19:1993;146-151.
96. Merzak A., Koocheckpour S., Pilkington G.J. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Research. 54:1994;3988-3992.
97. Mikkelsen T., Yan P.S., Ho K.L., Sameni M., Sloane B.F., Rosenblum M.L. Immunolocalization of cathepsin B in human glioma: Implications for tumor invasion and angiogenesis. Journal of Neurosurgery. 83:1995;285-290.
98. Milner R., Campbell I.L. The integrin family of cell adhesion molecules has multiple functions within the CNS. Journal of Neuroscience Research. 69:2002;286-291.
99. Mohanam S., Sawaya R., McCutcheon I., Ali-Osman F., Boyd D., Rao J.S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Research. 53:1993;4143-4147.
100. Mohanam S., Chintala S.K., Go Y., Bhattacharya A., Venkaiah B., Boyd D.et al. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 14:1997;1351-1359.
101. Mohanam S., Go Y., Sawaya R., Venkaiah B., Mohan P.M., Kouraklis G.P.et al. Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo. International Journal of Oncology. 14:1999;169-174.
102. Mohanam S., Jasti S.L., Kondraganti S.R., Chandrasekar N., Lakka S.S., Kin Y.et al. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene. 20:2001;3665-3673.
103. Mori T., Abe T., Wakabayashi Y., Hikawa T., Matsuo K., Yamada Y.et al. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor. Journal of Neurooncology. 46:2000;115-123.
104. Motamed K., Blake D.J., Angello J.C., Allen B.L., Rapraeger A.C., Hauschka S.D.et al. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: A role for protein kinase A. Journal of Cellular Biochemistry. 90:2003;408-423.
105. Munaut C., Noel A., Hougrand O., Foidart J.M., Boniver J., Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP. International Journal of Cancer. 106:2003;848-855.
106. Nakagawa S., Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development. 125:1998;2963-2971.
107. Nakagawa T., Kubota T., Kabuto M., Fujimoto N., Okada Y. Secretion of matrix metalloproteinase-2 (72. kDa gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: Implications for the growth and cellular invasion of the extracellular matrix Journal of Neurooncology. 28:1996;13-24.
108. Naot D., Sionov R.V., Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Advances in Cancer Research. 71:1997;241-319.
109. Obara S., Nakata M., Takeshima H., Kuratsu J., Maruyama I., Kitajima I. Inhibition of migration of human glioblastoma cells by cerivastatin in association with focal adhesion kinase (FAK). Cancer Letters. 185:2002;153-161.
110. Okada H., Yoshida J., Sokabe M., Wakabayashi T., Hagiwara M. Suppression of CD44 expression decreases migration and invasion of human glioma cells. International Journal of Cancer. 66:1996;255-260.
111. Okamoto I., Kawano Y., Tsuiki H., Sasaki J., Nakao M., Matsumoto M.et al. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 18:1999;1435-1446.
112. Okamoto I., Tsuiki H., Kenyon L.C., Godwin A.K., Emlet D.R., Holgado-Madruga M.et al. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. American Journal of Pathology. 160:2002;441-447.
113. Oohira A., Matsui F., Tokita Y., Yamauchi S., Aono S. Molecular interactions of neural chondroitin sulfate proteoglycans in the brain development. Archives in Biochemistry and Biophysics. 374:2000;24-34.
114. Owens G.C., Orr E.A., DeMasters B.K., Muschel R.J., Berens M.E., Kruse C.A. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. Cancer Research. 58:1998;2020-2028.
115. Oz B., Karayel F.A., Gazio N.L., Ozlen F., Balci K. The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathology Oncology Research. 6:2000;118-124.
116. Park M.J., Kim M.S., Park I.C., Kang H.S., Yoo H., Park S.H.et al. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Research. 62:2002;6318-6322.
117. Paulus W., Baur I., Beutler A.S., Reeves S.A. Diffuse brain invasion of glioma cells requires beta 1 integrins. Laboratory Investigation. 75:1996;819-826.
118. Paulus W., Baur I., Dours-Zimmermann M.T., Zimmermann D.R. Differential expression of versican isoforms in brain tumors. Journal of Neuropathology and Experimental Neurology. 55:1996;528-533.
119. Paulus W., Baur I., Schuppan D., Roggendorf W. Characterization of integrin receptors in normal and neoplastic human brain. American Journal of Pathology. 143:1993;154-163.
120. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 3:2003;347-361.
121. Pijuan-Thompson V., Grammer J.R., Stewart J., Silverstein R.L., Pearce S.F., Tuszynski G.P.et al. Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1. Experimental Cell Research. 249:1999;86-101.
122. Pilkington G.J., Akinwunmi J., Ognjenovic N., Rogers J.P. Differential binding of anti-CD44 on human gliomas in vitro. NeuroReport. 4:1993;259-262.
123. Pinkstaff K., Detterich J., Lynch G., Gall C. Integrin subunit gene expression is regionally differentiated in adult brain. Journal of Neuroscience. 19:1999;1541-1556.
124. Ponta H., Sherman L., Herrlich P.A. CD44: From adhesion molecules to signalling regulators. Nature Reviews: Molecular Cell Biology. 4:2003;33-45.
125. Pyke C., Kristensen P., Ralfkiaer E., Grondahl-Hansen J., Eriksen J., Blasi F.et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. American Journal of Pathology. 138:1991;1059-1067.
126. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proceedings of the National Academy of Sciences United States of America. 89:1992;1281-1285.
127. Raithatha S.A., Muzik H., Muzik H., Rewcastle N.B., Johnston R.N., Edwards D.R.et al. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neurooncology. 2:2000;145-150.
128. Ranuncolo S.M., Ladeda V., Specterman S., Varela M., Lastiri J., Morandi A.et al. CD44 expression in human gliomas. Journal of Surgical Oncology. 79:2002;30-35. (discussion 35-6).
129. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Research. 53:1993;2208-2211.
130. Rao J.S. Molecular mechanisms of glioma invasiveness: The role of proteases. Nature Reviews, Cancer. 3:2003;489-501.
131. Reardon D.A., Akabani G., Coleman R.E., Friedman A.H., Friedman H.S. II, Cokgor I.et al. Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. Journal of Clinical Oncology. 20:2002;1389-1397.
132. Rempel S.A., Rosenblum M.L., Mikkelsen T., Yan P.S., Ellis K.D., Golembieski W.A.et al. Cathepsin B expression and localization in glioma progression and invasion. Cancer Research. 54:1994;6027-6031.
133. Rempel S.A., Golembieski W.A., Ge S., Lemke N., Elisevich K., Mikkelsen T. SPARC: A signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. Journal of Neuropathology and Experimental Neurology. 57:1998;1112-1121.
134. Rempel S.A., Ge S., Gutierrez J.A. SPARC: A potential diagnostic marker of invasive meningiomas. Clinical Cancer Research. 5:1999;237-241.
135. Rempel S.A., Golembieski W.A., Fisher J.L., Maile M., Nakeff A. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. Journal of Neurooncology. 53:2001;149-160.
136. Resnati M., Guttinger M., Valcamonica S., Sidenius N., Blasi F., Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO Journal. 15:1996;1572-1582.
137. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M.et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proceedings of the National Academy of Sciences United States of America. 99:2002;1359-1364.
138. Roberts D.D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB Journal. 10:1996;1183-1191.
139. Rooprai H.K., Vanmeter T., Panou C., Schnull S., Trillo-Pazos G., Davies D.et al. The role of integrin receptors in aspects of glioma invasion in vitro. International Journal of Developmental Neuroscience. 17:1999;613-623.
140. Rosenblatt S., Bassuk J.A., Alpers C.E., Sage E.H., Timpl R., Preissner K.T. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: Characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochemistry Journal. 324:1997;311-319.
141. Sage E.H., Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. Journal of Biological Chemistry. 266:1991;14831-14834.
142. Sage E.H. Terms of attachment: SPARC and tumorigenesis. Nature Medicine. 3:1997;144-146.
143. Sasaki H., Yoshida K., Ikeda E., Asou H., Inaba M., Otani M.et al. Expression of the neural cell adhesion molecule in astrocytic tumors: An inverse correlation with malignancy. Cancer. 82:1998;1921-1931.
144. Sastry S.K., Burridge K. Focal adhesions: A nexus for intracellular signaling and cytoskeletal dynamics. Experimental Cell Research. 261:2000;25-36.
145. Sawaya R.E., Yamamoto M., Gokaslan Z.L., Wang S.W., Mohanam S., Fuller G.N.et al. Expression and localization of 72. kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo Clinical & Experimental Metastasis. 14:1996;35-42. (Sawaja 1996).
146. Schultz C., Lemke N., Ge S., Golembieski W.A., Rempel S.A. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Research. 62:2002;6270-6277.
147. Shinoura N., Paradies N.E., Warnick R.E., Chen H., Larson J.J., Tew J.J.et al. Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas. British Journal of Cancer. 72:1995;627-633.
148. Sivaparvathi M., Yamamoto M., Nicolson G.L., Gokaslan Z.L., Fuller G.N., Liotta L.A.et al. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clinical & Experimental Metastasis. 14:1996a;27-34.
149. Sivaparvathi M., Sawaya R., Chintala S.K., Go Y., Gokaslan Z.L., Rao J.S. Expression of cathepsin D during the progression of human gliomas. Neuroscience Letters. 208:1996b;171-174.
150. Sivaparvathi M., Sawaya R., Gokaslan Z.L., Chintala S.K., Rao J.S., Chintala K.S. Expression and the role of cathepsin H in human glioma progression and invasion. Cancer Letters. 104:1996c;121-126.
151. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
152. Takeichi M. Morphogenetic roles of classic cadherins. Current Opinion in Cell Biology. 7:1995;619-627.
153. Tenan M., Fulci G., Albertoni M., Diserens A.C., Hamou M.F., El Atifi-Borel M.et al. Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells. Journal of Experimental Medicine. 191:2000;1789-1798.
154. Tonn J.C., Kerkau S., Hanke A., Bouterfa H., Mueller J.G., Wagner S.et al. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. International Journal of Cancer. 80:1999;764-772.
155. Tonn J.C., Wunderlich S., Kerkau S., Klein C.E., Roosen K. Invasive behaviour of human gliomas is mediated by interindividually different integrin patterns. Anticancer Research. 18:1998;2599-2605.
156. Turk V., Turk B., Turk D. Lysosomal cysteine proteases: Facts and opportunities. EMBO Journal. 20:2001;4629-4633.
157. Tuszynski G.P., Rothman V., Murphy A., Siegler K., Smith L., Smith S.et al. Thrombospondin promotes cell-substratum adhesion. Science. 236:1987;1570-1573.
158. Tysnes B.B., Mahesparan R. Biological mechanisms of glioma invasion and potential therapeutic targets. Journal of Neurooncology. 53:2001;129-147.
159. Tysnes B.B., Larsen L.F., Ness G.O., Mahesparan R., Edvardsen K., Garcia-Cabrera I.et al. Stimulation of glioma-cell migration by laminin and inhibition by anti-alpha3 and anti-beta1 integrin antibodies. International Journal of Cancer. 67:1996;777-784.
160. Uhm J.H., Dooley N.P., Villemure J.G., Yong V.W. Glioma invasion in vitro: Regulation by matrix metalloprotease-2 and protein kinase C. Clinical & Experimental Metastasis. 14:1996;421-433.
161. Uhm J.H., Gladson C.L., Rao J.S. The role of integrins in the malignant phenotype of gliomas. Frontiers in Bioscience. 4:1999;D188-D199.
162. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Research. 305:2001;285-298.
163. VanMeter T.E., Rooprai H.K., Kibble M.M., Fillmore H.L., Broaddus W.C., Pilkington G.J. The role of matrix metalloproteinase genes in glioma invasion: Co-dependent and interactive proteolysis. Journal of Neurooncology. 53:2001;213-235.
164. Viapiano M.S., Matthews R.T., Hockfield S. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. Journal of Biological Chemistry. 278:2003;33239-33247.
165. Vleminckx K. Jr., Vakaet L., Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:1991;107-119.
166. Wang J.F., Park I.W., Groopman J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C. Blood. 95:2000;2505-2513.
167. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V.et al. Regulation of integrin function by the urokinase receptor. Science. 273:1996;1551-1555.
168. Wei Y., Eble J.A., Wang Z., Kreidberg J.A., Chapman H.A. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Molecular and Biological Cell. 12:2001;2975-2986.
169. Wei Y., Yang X., Liu Q., Wilkins J.A., Chapman H.A. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. Journal of Cell Biology. 144:1999;1285-1294.
170. Wen S., Stolarov J., Myers M.P., Su J.D., Wigler M.H., Tonks N.K.et al. PTEN controls tumor-induced angiogenesis. Proceedings of the National Academy of Sciences United States of America. 98:2001;4622-4627.
171. Wiranowska M., Tresser N., Saporta S. The effect of interferon and anti-CD44 antibody on mouse glioma invasiveness in vitro. Anticancer Research. 18:1998;3331-3338.
172. Yamamoto M., Sawaya R., Mohanam S., Bindal A.K., Bruner J.M., Oka K.et al. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Research. 54:1994;3656-3661.
173. Yang Q.W., Liu S., Tian Y., Salwen H.R., Chlenski A., Weinstein J.et al. Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. Cancer Research. 63:2003;6299-6310.
174. Yu Q., Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Development. 13:1999;35-48.
175. Zachary I. Focal adhesion kinase. International Journal of Biochemistry and Cell Biology. 29:1997;929-934.
176. Zagzag D., Friedlander D.R., Miller D.C., Dosik J., Cangiarella J., Kostianovsky M.et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Research. 55:1995;907-914.
177. Zagzag D., Friedlander D.R., Dosik J., Chikramane S., Chan W., Greco M.A.et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Research. 56:1996;182-189.
178. Zagzag D., Nomura M., Friedlander D.R., Blanco C.Y., Gagner J.P., Nomura N.et al. Geldanamycin inhibits migration of glioma cells in vitro: A potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. Journal of Cellular Physiology. 196:2003;394-402.
179. Zhang X., Bu X.Y., Zhen H.N., Fei Z., Zhang J.N., Fu L.A. Expression and localisation of urokinase-type plasminogen activator gene in gliomas. Journal of Clinical Neuroscience. 7:2000;116-119.